[HTML][HTML] Development and validation of a weakly supervised deep learning framework to predict the status of molecular pathways and key mutations in colorectal …

M Bilal, SEA Raza, A Azam, S Graham… - The Lancet Digital …, 2021 - thelancet.com
Background Determining the status of molecular pathways and key mutations in colorectal
cancer is crucial for optimal therapeutic decision making. We therefore aimed to develop a …

[HTML][HTML] Development and validation of a weakly supervised deep learning framework to predict the status of molecular pathways and key mutations in colorectal …

M Bilal, SEA Raza, A Azam, S Graham… - The Lancet. Digital …, 2021 - ncbi.nlm.nih.gov
Background Determining the status of molecular pathways and key mutations in colorectal
cancer is crucial for optimal therapeutic decision making. We therefore aimed to develop a …

Development and validation of a weakly supervised deep learning framework to predict the status of molecular pathways and key mutations in colorectal cancer from …

M Bilal, SEA Raza, A Azam, S Graham… - The Lancet. Digital …, 2021 - europepmc.org
Background Determining the status of molecular pathways and key mutations in colorectal
cancer is crucial for optimal therapeutic decision making. We therefore aimed to develop a …

[引用][C] Development and validation of a weakly supervised deep learning framework to predict the status of molecular pathways and key mutations in colorectal cancer …

M Bilal, SEA Raza, A Azam, S Graham, M Ilyas… - The Lancet Digital …, 2021 - cir.nii.ac.jp
Development and validation of a weakly supervised deep learning framework to predict the
status of molecular pathways and key mutations in colorectal cancer from routine histology …

Development and validation of a weakly supervised deep learning framework to predict the status of molecular pathways and key mutations in colorectal cancer from …

M Bilal, SEA Raza, A Azam… - The Lancet …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Determining the status of molecular pathways and key mutations in colorectal
cancer is crucial for optimal therapeutic decision making. We therefore aimed to develop a …

[HTML][HTML] Development and validation of a weakly supervised deep learning framework to predict the status of molecular pathways and key mutations in colorectal …

M Bilal, SEA Raza, A Azam, S Graham… - The Lancet Digital …, 2021 - thelancet.com
Background Determining the status of molecular pathways and key mutations in colorectal
cancer is crucial for optimal therapeutic decision making. We therefore aimed to develop a …

[HTML][HTML] Development and validation of a weakly supervised deep learning framework to predict the status of molecular pathways and key mutations in colorectal …

M Bilal, SEA Raza, A Azam, S Graham, M Ilyas… - The Lancet Digital …, 2021 - Elsevier
Background Determining the status of molecular pathways and key mutations in colorectal
cancer is crucial for optimal therapeutic decision making. We therefore aimed to develop a …

[PDF][PDF] Development and validation of a weakly supervised deep learning framework to predict the status of molecular pathways and key mutations in colorectal cancer …

M Bilal, SEA Raza, A Azam, S Graham, M Ilyas, IA Cree… - therapy, 2021 - researchgate.net
Background Determining the status of molecular pathways and key mutations in colorectal
cancer is crucial for optimal therapeutic decision making. We therefore aimed to develop a …

Development and validation of a weakly supervised deep learning framework to predict the status of molecular pathways and key mutations in colorectal cancer from …

M Bilal, SEA Raza, A Azam, S Graham… - The Lancet Digital …, 2021 - ksascholar.dri.sa
Background: Determining the status of molecular pathways and key mutations in colorectal
cancer is crucial for optimal therapeutic decision making. We therefore aimed to develop a …

Development and validation of a weakly supervised deep learning framework to predict the status of molecular pathways and key mutations in colorectal cancer from …

M Bilal, SA Raza, A Azam, S Graham… - The Lancet Digital …, 2021 - wrap.warwick.ac.uk
Background: Determining the status of molecular pathways and key mutations in colorectal
cancer is crucial for optimal therapeutic decision making. We therefore aimed to develop a …